0.65

4.07% -0.038

Abvc Biopharma Inc (ABVC)

Panoramica Notizia Cronologia dei prezzi Financials Perché ABVC Giù? Forum Previsione Frazionamento azionario

Precedente Chiudi:

$0.688

Aprire:

$0.6479

Volume 24 ore:

39,586

Relative Volume:

0.07

Capitalizzazione di mercato:

$15.64M

Reddito:

$152.40K

Utile/perdita netta:

$-10.52M

Rapporto P/E:

-0.2607

EPS:

-2.4931

Flusso di cassa netto:

$-4.26M

1 W Prestazione:

+3.35%

1M Prestazione:

+44.58%

6M Prestazione:

-4.91%

1 anno Prestazione:

-45.00%

Intervallo 1D:

$0.6403

$0.6797

Intervallo di 1 settimana:

$0.625

$0.74

Portata 52W:

$0.40

$1.73

Abvc Biopharma Inc Stock (ABVC) Company Profile

Nome

Abvc Biopharma Inc

Settore

Healthcare (1171)

Industria

Biotechnology (679)

Telefono

510-668-0881

Indirizzo

44370 OLD WARM SPRINGS BLVD., FREMONT

Dipendente

Cinguettio

Prossima data di guadagno

2024-12-13

Ultimi documenti SEC

ABVC's Discussions on Twitter

Confronta ABVC con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
ABVC Abvc Biopharma Inc	0.65	15.64M	152.40K	-10.52M	-4.26M	-2.4931
VRTX Vertex Pharmaceuticals Inc	510.04	130.68B	11.02B	-535.60M	-978.00M	-2.20
REGN Regeneron Pharmaceuticals Inc	670.18	74.97B	14.20B	4.41B	3.54B	38.28
ARGX Argen X Se Adr	602.20	36.08B	2.19B	833.04M	-1.28B	12.71
ALNY Alnylam Pharmaceuticals Inc	243.01	31.19B	2.25B	-278.16M	-42.59M	-2.17
ONC Beigene Ltd Adr	259.60	27.56B	3.32B	-860.46M	-1.04B	-8.32

Abvc Biopharma Inc Borsa (ABVC) Ultime notizie

Mar 07, 2025

ABVC BioPharma announces CFO resignation, CEO steps in as interim By Investing.com - Investing.com Canada

Mar 07, 2025

ABVC BioPharma announces CFO resignation, CEO steps in as interim - Investing.com India

Mar 07, 2025

ABVC Biopharma Inc On March 5, Leeds Chow Resigns As CFO Of Abvc Biopharma - Marketscreener.com

Mar 07, 2025

Mar 05, 2025

ABVC BioPharma Plans to Expand Investment in U.S. for Production Facilities and Products for Unmet Medical Needs - Financial Content

Mar 05, 2025

Feb 28, 2025

ABVC BioPharma's CEO Discusses New Drug Development and AI Integration - ACCESS Newswire

Feb 28, 2025

Feb 26, 2025

ABVC and BioLite Japan Forge Strategic Alliance to Boost Japanese Biotech Global Expansion - citybuzz -

Feb 26, 2025

ABVC and BioLite Japan Implement Strategy to Advance Japan's Biotech Innovation Into Global Markets - Financial Content

Feb 26, 2025

Feb 20, 2025

ABVC BioPharma Announces Potential $7M Cash Licensing Income from Existing Agreements in 2025 - Yahoo Finance

Feb 20, 2025

Feb 12, 2025

Positive Market Response in Asia Fuels Potential Revenue Growth for ABVC and BioKey, Marching Into Global Dietary Supplements Market of USD 75.35 Billion - Yahoo Finance

Feb 12, 2025

Jan 30, 2025

ABVC BioPharma, Inc. (NASDAQ:ABVC) Sees Large Decline in Short Interest - Defense World

Jan 30, 2025

Jan 16, 2025

ABVC BioPharma and AiBtl BioPharma's Worldwide Business Development Team Participate in the 43rd Annual J.P. Morgan Healthcare Conference - Yahoo Finance

Jan 16, 2025

ABVC BioPharma, Inc. (NASDAQ:ABVC) Short Interest Down 42.6% in December - Defense World

Jan 16, 2025

Jan 15, 2025

ABVC BioPharma s ADHD and MDD Drug Polygala Tenuifolia a Natural Wonder With Potential of Transforming Mental Health Treatment of More Than 30 Billion Market - Yahoo Finance

Jan 15, 2025

Jan 14, 2025

AiBtl BioPharma Strengthens Partnership With ABVC BioPharma, Paying $150,000 in Licensing Fees - Yahoo Finance

Jan 14, 2025

Head to Head Review: ABVC BioPharma (NASDAQ:ABVC) vs. Rhythm Pharmaceuticals (NASDAQ:RYTM) - Defense World

Jan 14, 2025

Jan 13, 2025

ABVC BioPharma, Inc. Granted Additional 180-Day Grace Period to Regain Compliance With Nasdaq Bid Price Requirement - Yahoo Finance

Jan 13, 2025

Jan 07, 2025

ABVC BioPharma and ForSeeCon: An Update on Alliance's Ophthalmology-Related Products - Yahoo Finance

Jan 07, 2025

Jan 03, 2025

ABVC BioPharma Expands Global Patent Portfolio for ADHD Treatment - Citybuzz

Jan 03, 2025

Jan 02, 2025

ABVC BioPharma Secures an Additional Patent for ADHD Treatment, in Addition to the Granted U.S. and Australian Patents, Moving Forward to the Global Patent Map of $32.14 Billion Potential Market - Yahoo Finance

Jan 02, 2025

Dec 28, 2024

Short Interest in ABVC BioPharma, Inc. (NASDAQ:ABVC) Rises By 148.2% - Defense World

Dec 28, 2024

Dec 19, 2024

ABVC BioPharma Seeks to Revolutionize Mental Health Treatment With a Safe Prozac Alternative, Boasting a MADRS Score Reduction of -13.21 - The Manila Times

Dec 19, 2024

ABVC BioPharma Seeks to Revolutionize Mental Health - GlobeNewswire

Dec 19, 2024

ABVCAbvc Biopharma Inc Latest Stock News & Market Updates - StockTitan

Dec 19, 2024

Dec 13, 2024

ABVC BioPharma, Inc. (NASDAQ:ABVC) Short Interest Down 24.2% in November - Defense World

Dec 13, 2024

Dec 11, 2024

ABVC BioPharma Secures $200,000 in First Cash Licensing Payment From Oncology Products Partner, Totaling $546,000 From Three Partners - The Manila Times

Dec 11, 2024

ABVC BioPharma Secures $200,000 in First Cash Licensing - GlobeNewswire

Dec 11, 2024

ABVC BioPharma Secures Major Oncology Licensing Deal: $200K Initial Payment, Up to $50M in Future Royalties - StockTitan

Dec 11, 2024

Nov 28, 2024

Short Interest in ABVC BioPharma, Inc. (NASDAQ:ABVC) Rises By 79.2% - Defense World

Nov 28, 2024

Nov 16, 2024

ABVC BioPharma Inc. Reports Operational Profit and Income Growth in Q3 2024 - Defense World

Nov 16, 2024

Nov 15, 2024